Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Exaggerated inflammatory response after use of recombinant bone morphogenetic protein in recurrent unicameral bone cysts.

MacDonald KM, Swanstrom MM, McCarthy JJ, Nemeth BA, Guliani TA, Noonan KJ.

J Pediatr Orthop. 2010 Mar;30(2):199-205. doi: 10.1097/BPO.0b013e3181cec35b.

PMID:
20179570
2.

Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?

Hiremath GK, Steinmetz MP, Krishnaney AA.

Spine (Phila Pa 1976). 2009 Apr 20;34(9):885-9. doi: 10.1097/BRS.0b013e31819e334a.

PMID:
19531997
3.

Complications associated with the use of bone morphogenetic protein in pediatric patients.

Oetgen ME, Richards BS.

J Pediatr Orthop. 2010 Mar;30(2):192-8. doi: 10.1097/BPO.0b013e3181d075ab.

PMID:
20179569
4.

Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion.

Tumialán LM, Rodts GE.

Spine J. 2007 Jul-Aug;7(4):509-10. Epub 2007 May 15. No abstract available.

PMID:
17526433
5.

rh-BMP-2 can be used safely in the cervical spine: dose and containment are the keys!

Dickerman RD, Reynolds AS, Morgan BC, Tompkins J, Cattorini J, Bennett M.

Spine J. 2007 Jul-Aug;7(4):508-9. Epub 2007 Apr 19. No abstract available.

PMID:
17521966
6.

Adverse events in patients re-exposed to bone morphogenetic protein for spine surgery.

Carreon LY, Glassman SD, Brock DC, Dimar JR, Puno RM, Campbell MJ.

Spine (Phila Pa 1976). 2008 Feb 15;33(4):391-3. doi: 10.1097/BRS.0b013e3181642a49.

PMID:
18277870
7.

Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.

Crawford CH 3rd, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD.

Spine (Phila Pa 1976). 2009 Jun 1;34(13):1390-4. doi: 10.1097/BRS.0b013e3181a2da08.

PMID:
19440166
8.

Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.

Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG.

Spine (Phila Pa 1976). 2006 Nov 15;31(24):2813-9.

PMID:
17108835
9.

Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB.

Spine (Phila Pa 1976). 2006 Mar 1;31(5):542-7.

PMID:
16508549
10.

Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".

Bennett M, Reynolds AS, Dickerman RD.

Spine (Phila Pa 1976). 2006 Aug 1;31(17):2029-30. No abstract available.

PMID:
16924224
11.
12.

Avoiding unanticipated adverse effects of recombinant human bone morphogenetic protein-2 therapy in craniofacial surgery with experiences from spinal applications.

Smoljanovic T, Janjanin S, Bojanic I.

J Craniofac Surg. 2009 Sep;20(5):1626. doi: 10.1097/SCS.0b013e3181b17f81. No abstract available.

PMID:
19816316
13.

Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2.

O'Shaughnessy BA, Kuklo TR, Ondra SL.

Spine (Phila Pa 1976). 2008 Mar 1;33(5):E132-9. doi: 10.1097/BRS.0b013e3181657ee3.

PMID:
18317180
14.

Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment.

Sasso RC, LeHuec JC, Shaffrey C; Spine Interbody Research Group.

J Spinal Disord Tech. 2005 Feb;18 Suppl:S77-81.

PMID:
15699810
15.

Outcomes of bone morphogenetic protein-2 in mature adults: posterolateral non-instrument-assisted lumbar decompression and fusion.

Hamilton DK, Jones-Quaidoo SM, Sansur C, Shaffrey CI, Oskouian R, Jane JA Sr.

Surg Neurol. 2008 May;69(5):457-61; discussion 461-2. doi: 10.1016/j.surneu.2007.09.008. Epub 2008 Jan 18.

PMID:
18207557
17.

Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Poynton AR, Lane JM.

Spine (Phila Pa 1976). 2002 Aug 15;27(16 Suppl 1):S40-8. Review.

PMID:
12205419
18.

Bone morphogenetic proteins in orthopaedic surgery.

Axelrad TW, Einhorn TA.

Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):481-8. doi: 10.1016/j.cytogfr.2009.10.003. Epub 2009 Nov 4. Review.

PMID:
19892584
19.

Recombinant human bone morphogenetic proteins in the treatment of fractures.

Kain MS, Einhorn TA.

Foot Ankle Clin. 2005 Dec;10(4):639-50, viii. Review.

PMID:
16297824
20.

Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.

Maeda T, Buchowski JM, Kim YJ, Mishiro T, Bridwell KH.

Spine (Phila Pa 1976). 2009 Sep 15;34(20):2205-12. doi: 10.1097/BRS.0b013e3181b0485c.

PMID:
19752707

Supplemental Content

Support Center